BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20011040)

  • 1. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
    Bate C; Tayebi M; Williams A
    J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
    Bate C; Nolan W; Williams A
    J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.
    Bate C; Tayebi M; Williams A
    Neuropharmacology; 2010; 59(1-2):93-9. PubMed ID: 20398681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
    Bate C; Tayebi M; Williams A
    BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
    Bate C; Salmona M; Diomede L; Williams A
    J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride reduces CD14 expression and cytokine secretion from macrophages.
    Ingham V; Williams A; Bate C
    J Neuroinflammation; 2014 Jun; 11():115. PubMed ID: 24952384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
    Bate C; Williams A
    Prion; 2012; 6(4):350-3. PubMed ID: 22895089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an intracellular site of prion conversion.
    Marijanovic Z; Caputo A; Campana V; Zurzolo C
    PLoS Pathog; 2009 May; 5(5):e1000426. PubMed ID: 19424437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
    Bate C; Nolan W; Williams A
    Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins.
    Bate C; Williams A
    J Biol Chem; 2012 Mar; 287(11):7935-44. PubMed ID: 22262833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.
    Bate C; Williams A
    Prion; 2011; 5(2):65-8. PubMed ID: 21738009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation.
    Westaway D; Genovesi S; Daude N; Brown R; Lau A; Lee I; Mays CE; Coomaraswamy J; Canine B; Pitstick R; Herbst A; Yang J; Ko KW; Schmitt-Ulms G; Dearmond SJ; McKenzie D; Hood L; Carlson GA
    PLoS Pathog; 2011 Nov; 7(11):e1002391. PubMed ID: 22114562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
    Giese A; Kretzschmar HA
    Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of Prion Protein and the Family Member, Shadoo.
    Onodera T; Nishimura T; Sugiura K; Sakudo A
    Curr Issues Mol Biol; 2020; 36():67-88. PubMed ID: 31559969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.